Feasibility and Preliminary Outcomes of a Web and Smartphone–Based Medication Self-Management Platform for Chronically Ill Patients

  • Helena Anglada-Martínez
  • Maite Martin-Conde
  • Marina Rovira-Illamola
  • Jose Miguel Sotoca-Momblona
  • Ethel Sequeira
  • Valentin Aragunde
  • M. Angels Moreno
  • Marta Catalan
  • Carles Codina-Jané
Mobile Systems
Part of the following topical collections:
  1. Mobile Systems

Abstract

Objective

The aim of this study was to assess the feasibility and preliminary outcomes of a medication self-management platform for chronically ill patients, Medplan.

Methods

We performed a 6-month single-arm prospective pre-post intervention study of patients receiving treatment for hypertension and/or dyslipidemia and/or heart failure and/or human immunodeficiency virus infection. During the pre-intervention phase, participants were followed according to their usual care; during the intervention phase, they used Medplan. We evaluated adherence, health outcomes, healthcare resources and measured the satisfaction of patients and health care professionals.

Results

The study population comprised 42 patients. No differences were found in adherence to medication measured by proportion of days covered with medication (PDC). However, when adherence was measured using the SMAQ, the percentage of adherent patients improved during the intervention phase (p < 0.05), and the number of days with missed doses decreased (p < 0.05). Adherence measured using the Medplan app showed poor concordance with PDC. No differences were found in health outcomes or in the use of health care resources during the study period. The mean satisfaction score for Medplan was 7.2 ± 2.7 out of 10 among patients and 7.3 ± 1.7 among health care professionals. In fact, 71.4 % of participants said they would recommend the app to a friend, and 88.1 % wanted to continue using it.

Conclusion

The Medplan platform proved to be feasible and was well accepted by its users. However, its impact on adherence differed depending on the assessment method. The lack of effect on PDC is mainly because patients were already good adherers at baseline. The study enabled us to validate the platform in real patients using many different mobile devices and to identify potential barriers to scaling up the platform.

Keywords

Mobile phones Chronic patients Medication adherence Applications 

Notes

Compliance with Ethical Standards

Conflict of Interest

Authors have no conflict of interest to declare.

References

  1. 1.
    Osterberg, L., and Blaschke, T., Adherence to medication. N. Engl. J. Med. 353(5):487–497, 2005. doi: 10.1056/NEJMra050100.CrossRefPubMedGoogle Scholar
  2. 2.
    WHO | ADHERENCE TO LONG-TERM THERAPIES: EVIDENCE FOR ACTION. World Health Organization http://www.who.int/chp/knowledge/publications/adherence_report/en/. Accessed February 19, 2014.
  3. 3.
    Viswanathan, M., Golin, C. E., Jones, C. D., et al., Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann. Intern. Med. 157(11):785–795, 2012. doi: 10.7326/0003-4819-157-11-201212040-00538.CrossRefPubMedGoogle Scholar
  4. 4.
    Garfield, S., Clifford, S., Eliasson, L., Barber, N., and Willson, A., Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med. Res. Methodol. 11:149, 2011. doi: 10.1186/1471-2288-11-149.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Ho, P. M., Bryson, C. L., and Rumsfeld, J. S., Medication adherence: its importance in cardiovascular outcomes. Circulation 119(23):3028–3035, 2009. doi: 10.1161/CIRCULATIONAHA.108.768986.CrossRefPubMedGoogle Scholar
  6. 6.
    Bosworth, H. B., Granger, B. B., Mendys, P., et al., Medication adherence: a call for action. Am. Heart J. 162(3):412–424, 2011. doi: 10.1016/j.ahj.2011.06.007.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Anglada-Martinez, H., Riu-Viladoms, G., Martin-Conde, M., Rovira-Illamola, M., Sotoca-Momblona, J. M., and Codina-Jane, C., Does mHealth increase adherence to medication? Results of a systematic review. Int. J. Clin. Pract. 69(1):9–32, 2014. doi: 10.1111/ijcp.12582.CrossRefPubMedGoogle Scholar
  8. 8.
    Hamine, S., Gerth-Guyette, E., Faulx, D., Green, B. B., and Ginsburg, A. S., Impact of mHealth Chronic Disease Management on Treatment Adherence and Patient Outcomes: A Systematic Review. J. Med. Internet Res. 17(2):e52, 2015. doi: 10.2196/jmir.3951.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Lester, R. T., Ritvo, P., Mills, E. J., et al., Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 376(9755):1838–1845, 2010. doi: 10.1016/S0140-6736(10)61997-6.CrossRefPubMedGoogle Scholar
  10. 10.
    Pop-Eleches, C., Thirumurthy, H., Habyarimana, J. P., et al., Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS 25(6):825–834, 2011. doi: 10.1097/QAD.0b013e32834380c1.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Mbuagbaw, L., Thabane, L., Ongolo-Zogo, P., et al., The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One 7(12):e46909, 2012. doi: 10.1371/journal.pone.0046909.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Strandbygaard, U., Thomsen, S. F., and Backer, V., A daily SMS reminder increases adherence to asthma treatment: a three-month follow-up study. Respir. Med. 104(2):166–171, 2010. doi: 10.1016/j.rmed.2009.10.003.CrossRefPubMedGoogle Scholar
  13. 13.
    Petrie, K. J., Perry, K., Broadbent, E., and Weinman, J., A text message programme designed to modify patients’ illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br. J. Health Psychol. 17(1):74–84, 2012. doi: 10.1111/j.2044-8287.2011.02033.x.CrossRefPubMedGoogle Scholar
  14. 14.
    Park, L. G., Howie-Esquivel, J., Chung, M. L., and Dracup, K., A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Educ. Couns. 94(2):261–268, 2014. doi: 10.1016/j.pec.2013.10.027.CrossRefPubMedGoogle Scholar
  15. 15.
    Márquez Contreras, E., de la Figuera von Wichmann, M., Gil Guillén, V., et al., Effectiveness of an intervention to provide information to patients with hypertension as short text messages and reminders sent to their mobile phone (HTA-Alert). Aten. Primaria 34(8):399–405, 2004. http://www.ncbi.nlm.nih.gov/pubmed/15546536. Accessed February 19, 2014.CrossRefPubMedGoogle Scholar
  16. 16.
    Bert, F., Giacometti, M., Gualano, M. R., and Siliquini, R., Smartphones and health promotion: a review of the evidence. J. Med. Syst. 38(1):9995, 2014. doi: 10.1007/s10916-013-9995-7.CrossRefPubMedGoogle Scholar
  17. 17.
    “Global Mobile Health Trends and Figures Market Report 2013–2017.” http://research2guidance.com/500m-people-will-be-using-healthcare-mobile-applications-in-2015/. Accessed June 30, 2014.
  18. 18.
    mHealth. Healthcare mobile apps, devices and solutions. Infographic. http://www.ticbeat.com/sim/contribucion-moviles-salud-infografia/ Accessed February 19, 2014.
  19. 19.
    Patel, S., Jacobus-Kantor, L., Marshall, L., et al., Mobilizing your medications: an automated medication reminder application for mobile phones and hypertension medication adherence in a high-risk urban population. J. Diabetes Sci. Technol. 7(3):630–639, 2013. http://www.ncbi.nlm.nih.gov/pubmed/23759395. Accessed February 19, 2014.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Mobile Pillbox App Promotes Diabetes Medication Adherence: Report [Internet]. http://www.eweek.com/mobile/mobile-pillbox-app-promotes-diabetes-medication-adherence-Report/. Accessed February 19, 2014.
  21. 21.
    Ryan, D., Price, D., Musgrave, S. D., et al., Clinical and cost effectiveness of mobile phone supported self monitoring of asthma: multicentre randomised controlled trial. BMJ 344:e1756, 2012. doi: 10.1136/bmj.e1756.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Cano Martín, J. A., Martínez-Pérez, B., de la Torre-Díez, I., and López-Coronado, M., Economic impact assessment from the use of a mobile app for the self-management of heart diseases by patients with heart failure in a Spanish region. J. Med. Syst. 38(9):96, 2014. doi: 10.1007/s10916-014-0096-z.CrossRefPubMedGoogle Scholar
  23. 23.
    Grindrod, K. A., Li, M., and Gates, A., Evaluating user perceptions of mobile medication management applications with older adults: a usability study. JMIR mHealth uHealth 2(1):e11, 2014. doi: 10.2196/mhealth.3048.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Al Ghamdi, E., Yunus, F., Da’ar, O., et al., The Effect of Screen Size on Mobile Phone User Comprehension of Health Information and Application Structure: An Experimental Approach. J. Med. Syst. 40(1):11, 2016. doi: 10.1007/s10916-015-0381-5.CrossRefPubMedGoogle Scholar
  25. 25.
    Zapata, B. C., Fernández-Alemán, J. L., Idri, A., and Toval, A., Empirical studies on usability of mHealth apps: a systematic literature review. J. Med. Syst. 39(2):1, 2015. doi: 10.1007/s10916-014-0182-2.CrossRefPubMedGoogle Scholar
  26. 26.
    Herdman, M., Badia, X., and Berra, S., El EuroQol-5D: una alternativa sencilla para la medición de la calidad de vida relacionada con la salud en atención primaria. Aten. Primaria 28(06):425–430, 2001.CrossRefPubMedGoogle Scholar
  27. 27.
    Knobel, H., Alonso, J., Casado, J. L., et al., Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS 16(4):605–613, 2002.CrossRefPubMedGoogle Scholar
  28. 28.
    Shalansky, S. J., Levy, A. R., and Ignaszewski, A. P., Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann. Pharmacother. 38(9):1363–1368, 2004. doi: 10.1345/aph.1E071.CrossRefPubMedGoogle Scholar
  29. 29.
    Morisky, D. E., Green, L. W., and Levine, D. M., Concurrent and predictive validity of a self-reported measure of medication adherence. Med. Care 24(1):67–74, 1986.CrossRefPubMedGoogle Scholar
  30. 30.
    Ortega Suárez, F. J., Sánchez Plumed, J., Pérez Valentín, M. A., Pereira Palomo, P., Muñoz Cepeda, M. A., and Lorenzo, A. D., Validation on the simplified medication adherence questionnaire (SMAQ) in renal transplant patients on tacrolimus. Nefrologia 31(6):690–696, 2011. doi: 10.3265/Nefrologia.pre2011.Aug.10973.PubMedGoogle Scholar
  31. 31.
    Haynes, R. B., McKibbon, K. A., and Kanani, R., Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 348(9024):383–386, 1996.CrossRefPubMedGoogle Scholar
  32. 32.
    Horne, R., and Weinman, J., Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J. Psychosom. Res. 47(6):555–567, 1999.CrossRefPubMedGoogle Scholar
  33. 33.
    Labrecque, M., Laurier, C., Champagne, F., Kennedy, W., Paré, M., and Cartier, A., Effect of age on the conformity rate to short-acting beta-agonist use criteria in asthma. J. Asthma 40(7):829–835, 2003.CrossRefPubMedGoogle Scholar
  34. 34.
    Degli Esposti, E., Di Martino, M., Sturani, A., et al., Risk factors for uncontrolled hypertension in Italy. J. Hum. Hypertens. 18(3):207–213, 2004. doi: 10.1038/sj.jhh.1001656.CrossRefPubMedGoogle Scholar
  35. 35.
    Mbuagbaw, L., van der Kop, M. L., Lester, R. T., et al., Mobile phone text messages for improving adherence to antiretroviral therapy (ART): an individual patient data meta-analysis of randomised trials. BMJ Open 3(12):e003950, 2013. doi: 10.1136/bmjopen-2013-003950.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    McCarney, R., Warner, J., Iliffe, S., van Haselen, R., Griffin, M., and Fisher, P., The Hawthorne Effect: a randomised, controlled trial. BMC Med. Res. Methodol. 7:30, 2007. doi: 10.1186/1471-2288-7-30.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Goldstein, C. M., Gathright, E. C., Dolansky, M. A., et al., Randomized controlled feasibility trial of two telemedicine medication reminder systems for older adults with heart failure. J. Telemed. Telecare 20(6):293–299, 2014. doi: 10.1177/1357633X14541039.CrossRefPubMedGoogle Scholar
  38. 38.
    Mira, J. J., Navarro, I., Botella, F., et al., A Spanish pillbox app for elderly patients taking multiple medications: randomized controlled trial. J. Med. Internet Res. 16(4):e99, 2014. doi: 10.2196/jmir.3269.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    ¿Conoce Canal Paciente? - Noticias - CAPs Les Corts, Casanova i Comte Borrell. http://www.capcasanova.cat/es_noticies/view.php?ID=154. Accessed April 29, 2015.
  40. 40.
    McGillicuddy, J. W., Weiland, A. K., Frenzel, R. M., et al., Patient attitudes toward mobile phone-based health monitoring: questionnaire study among kidney transplant recipients. J. Med. Internet Res. 15(1):e6, 2013. doi: 10.2196/jmir.2284.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Helena Anglada-Martínez
    • 1
  • Maite Martin-Conde
    • 1
  • Marina Rovira-Illamola
    • 1
  • Jose Miguel Sotoca-Momblona
    • 1
  • Ethel Sequeira
    • 2
  • Valentin Aragunde
    • 2
  • M. Angels Moreno
    • 2
  • Marta Catalan
    • 2
  • Carles Codina-Jané
    • 1
  1. 1.Pharmacy ServiceHospital Clínic BarcelonaBarcelonaSpain
  2. 2.Consorci d’Atenció Primària de l’Eixample Casanova, GrupTransversal de Recerca en Atenció PrimàriaIDIBAPS, University of BarcelonaBarcelonaSpain

Personalised recommendations